A Double-Blind, Placebo-Controlled, Randomized, Single-Dose, 2-Period Crossover Study of the Pharmacodynamics of Orally Administered PSI-697 in Healthy Subjects Who Smoke
Phase of Trial: Phase I
Latest Information Update: 12 Apr 2012
At a glance
- Drugs PSI 697 (Primary)
- Indications Thrombosis
- Focus Pharmacodynamics
- 15 Aug 2008 New trial record.